Self-Assessment Post-Test

SELF-ASSESSMENT POST-TEST There are no fees for participating and receiving CME credit for this activity. During the period of April 2004 through April 30, 2005, participants must: 1) read the learning objectives and faculty disclosures; 2) study the educational activity; 3) complete the post-test by recording the best answer to each question in the answer key on the evaluation form; 4) complete the evaluation form; and 5) mail or fax the evaluation form with answer key to Postgraduate Institute for Medicine. The State of Urinary Incontinence in Women 1. According to the International Continence Society’s classification system, the involuntary leakage of urine during increased abdominal pressure, in the absence of a detrusor contraction, is the ___ of stress urinary incontinence (SUI). a. Symptom b. Sign c. Urodynamic observation d. Condition 7. The 2nd International Consultation on Incontinence concluded that biofeedback-assisted pelvic floor muscle training (PFMT) is better than PFMT alone. a. True b. False 8. Which of the following is/are associated with an increased risk of SUI? a. Obesity b. Advanced age c. Smoking d. All of the above Compared with the Marshall-Marchetti-Krantz procedure, Burch colposuspension places the sutures more proximal and lateral with respect the urethra and bladder neck. a. True b. False 9. During the storage phase of micturition, glutamatergic transmission at the pudendal nerve is turned: a. On b. Off 3. Type III SUI, as classified by Blaivas and Olsson, is characterized by: a. A flat bladder base below the pubis at rest b. A marked descent of the bladder base with coughing c. A fixed open urethra and vesical neck d. All of the above 4. All women with proximal pressure transmission ratios under 90% experience stress incontinence. a. True b. False 10. Which of the following statements is not true? a. Duloxetine facilitates sphincter activity during urine storage but not during voiding. b. Duloxetine is a competitive inhibitor of cytochrome P450 2D6. c. Duloxetine is excreted primarily in the feces. d. Duloxetine acts centrally in the lower spinal cord. 5. The smooth muscles of the bladder detrusor are innervated primarily by: a. Sympathetic nerves b. Parasympathetic nerves c. Somatic nerves d. None of the above 2. 6. Which of the following neurotransmitters is/are involved in the functioning of the lower urinary tract? a. -Aminobutyric acid b. Glutamic acid c. Norepinephrine d. Dopamine e. All of the above 11. The Patient Global Impression of Improvement scale: a. Is a single-item measure of patient approbation of therapy b. Is considered by the World Health Organization to be the primary quality of life measure for SUI c. Has been validated in women with SUI d. Answers a and c e. All of the above 12. In clinical trials, duloxetine has been shown to: a. Significantly decrease incontinence episode frequency compared with placebo b. Significantly improve Incontinence Quality of Life score compared with placebo c. Significantly increase the voiding interval d. All of the above EVALUATION FORM The State of Urinary Incontinence in Women Project ID: 1603 ES 13 Postgraduate Institute for Medicine (PIM) respects and appreciates your opinions. To assist us in evaluating the effectiveness of this activity and to make recommendations for future educational offerings, please take a few minutes to complete this evaluation form. You must complete this evaluation form to receive acknowledgment of participation for this activity. Please Print Clearly Name: Address: City: Phone Number: E-mail: State: Specialty: Box/Suite: Zip Code: Fax Number: VOL. 6 SUPPL. 3 2004 REVIEWS IN UROLOGY S65 Answer key: 1. c, 2. d, 3. c, 4. b, 5. b, 6. e, 7. b, 8. a, 9. a, 10. c, 11. d, 12. d Please answer the following questions by circling the appropriate rating: (5 = Outstanding; 4 = Good; 3 = Satisfactory; 2 = Fair; 1 = Poor) EXTENT TO WHICH PROGRAM ACTIVITIES MET THE IDENTIFIED OBJECTIVES Upon completion of this activity, participants should be able to: • Describe the epidemiology and pathophysiology of SUI 5 • Discuss the role of neurotransmitters and the micturition reflex in the lower urinary tract 5 • Evaluate existing therapies for SUI 5 • Review the characteristics of an optimal therapy for the management of patients with SUI 5 • Discuss new treatment options for SUI 5 OVERALL EFFECTIVENESS OF THE ACTIVITY • Objectives were related to overall purpose/goal(s) of activity • Related to my practice needs • Will influence how I practice • Will help me improve patient care • Stimulated my intellectual curiosity • Overall quality of material • Overall, the activity met my expectations • Avoided commercial bias or influence 5 5 5 5 5 5 5 Will the information presented cause you to make any changes in your practice? If yes, please describe any change(s) you plan to make in your practice as a result of this activity: How committed are you to making these changes? 4 3 2 1 4 4 3 3 2 2 1 1 4 4 3 3 2 2 1 1 4 4 4 4 4 4 4 3 3 3 3 3 3 3 2 2 2 2 2 2 2 1 1 1 1 1 1 1 Yes___ No___ 5 4 (Very) 3 2 Additional comments about this activity: Do you feel future activities on this subject matter are necessary and/or important to your practice? Please list any other topics that would be of interest to you for future educational activities: Degree: ❒ MD ❒ DO ❒ PharmD ❒ RN Yes___ No___ ❒ PA ❒ BS ❒ Other: To obtain a statement of participation, you must complete the post-test by selecting the best answer to each question, complete the evaluation form, and mail or fax your completed evaluation form to Postgraduate Institute for Medicine. POST-TEST ANSWER KEY 1___ 2___ 3___ 4___ 5___ 6___ 7___ 8___ 9___ 10___ 11___ 12___ ❒ I participated in the entire activity and claim 2.0 credits. ❒ I participated in only part of the activity and claim ____ credits. Signature: If you wish to receive credit for this activity, please fill in your name and address and mail/fax to: Postgraduate Institute for Medicine PO Box 260620 Littleton, CO 80163-0620 Fax: (303) 790-4876 Release date: April 2004 Expiration: Credit will be awarded for required materials postmarked or received no later than April 30, 2005. Certificates will be mailed within 1 month of receipt of these materials. S66 VOL. 6 SUPPL. 3 2004 REVIEWS IN UROLOGY 1 (Not at all)